… This review will focus on the side effect profile of everolimus … management of frequently
encountered toxicities. Given, the impressive efficacy of everolimus in metastatic breast cancer, it …

… The safety profile and protocols for toxicity management are well established. The class-effect
adverse event profile observed with everolimus plus endocrine therapy in breast cancer is …

… MESH terms: ‘everolimus’ AND ‘side‑effects’ OR ‘toxicities’ OR ‘… Everolimus in particular,
is clinically used for the treatment of … 2 (HER-2)-negative breast cancer, renal cell carcinoma, …

… The most common unique adverse events observed in everolimus clinical trials in breast
cancer … At that point, the nurse makes an assessment for early everolimus side effects such as …

… can modify plasmatic concentrations of everolimus and affect its efficacy and toxicity. The
patient's … Cost, side effect profile, and disease aggressiveness at time of progression after each …

… and well known side effect of using mTOR inhibitors. The spectrum of hematologic toxicities
… rather ubiquitous hematologic toxicities encountered during everolimus treatment, the most …

… the use of everolimus in HR-positive breast cancer patients in … but also describe in detail
the side effect profile of this drug. … breast cancer; it also demonstrated that despite the toxicity …

… be maintained despite everolimus dose reductions required to manage toxicities, such as …
for early detection and management of toxicity. The appropriate management of AEs will …

… breast cancer (MBC). The aim of this study is to evaluate the efficacy and toxicity of everolimus
… One of the most common side effects of everolimus plus exemestane is stomatitis, which …

… in breast cancer cells. The role of everolimus in breast cancer was established in the
Breast … Everolimus toxicities are generally mild as reported in published literature, however …